Mohammad Mehdi Akbarin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Mehdi Akbarin has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Zahra Farjami
Virology, Genetics, and Molecular Biology Laboratory, Faculty of Higher Studies Cuautitlan, Veterinary Medicine, Campus 4 National Autonomous University of Mexico Cuautitlan Izcalli Mexico
8 shared publications- Seyed Abdolrahim Rezaee
Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications - Arman Mosavat
Blood Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR), Razavi Khorasan, Mashhad, Iran
2 shared publications - Houshang Rafatpanah
Immunology Research Center Division of Inflammation and Inflammatory Diseases Mashhad University of Medical Sciences Mashhad Iran
2 shared publications - Hugo Ramírez Álvarez
Virology, Genetics, and Molecular Biology Laboratory, Faculty of Higher Studies Cuautitlan, Veterinary Medicine, National Autonomous University of Mexico, Cuautitlán Izcalli, Mexico
2 shared publications Mina Moradi
Department of Chemistry, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Wiley in Animal Genetics
- Vol. 57 (3) , e70136
Stage‐Dependent Transcriptional Reprogramming of B‐Cell Receptor Signaling and Antigen Presentation During Bovine Leukemia Virus–Driven Lymphomagenesis
Bovine leukemia virus (BLV), an oncogenic deltaretrovirus, establishes lifelong infection in cattle and induces enzootic bovine leukosis in a subset of animals following prolonged latency. Despite extensive evidence of immune dysregulation, stage‐specific transcriptional reprogramming of B cells, the primary viral reservoir remains incompletely understood. In this study, we performed a targeted RNA‐sequencing analysis to characterize B‐cell–associated transcriptional profiles across three clinical stages: uninfected controls (CT), asymptomatic BLV‐infected cattle (AC), and persistent lymphocytosis (PL). Differential gene expression analysis revealed a dynamic, stage‐dependent remodeling of B‐cell immune functions. Asymptomatic infection was characterized by significant upregulation of key B‐cell receptor (BCR) signaling components, including CD79B and SYK , alongside increased expression of major histocompatibility complex class II genes ( BoLA‐DRA, BoLA‐DRB3 ) and immunoglobulin assembly gene JCHAIN , indicating enhanced antigen responsiveness and partial activation of antibody‐related pathways. However, transcriptional regulators of terminal plasma cell differentiation ( PRDM1 and XBP1 ) remained unchanged, suggesting incomplete maturation. In contrast, progression to persistent lymphocytosis was associated with attenuation of canonical BCR signaling and reduced expression of antigen presentation and immunoglobulin assembly genes relative to the asymptomatic stage. Notably, germinal center–associated transcription factors ( BCL6, AICDA, RGS13, MEF2B ) remained largely unchanged across all comparisons, indicating that BLV‐driven lymphomagenesis does not resemble a classical germinal center–derived process. Collectively, these findings support a biphasic model of BLV‐induced B‐cell modulation, characterized by early immune activation followed by functional reprogramming and immune attenuation during disease progression. This stage‐dependent remodeling provides new mechanistic insights into BLV pathogenesis and B‐cell transformation.
- 5 June 2026
- Published by Wiley in Animal Genetics
- Vol. 57 (3) , e70136
Open AccessStage‐Dependent Transcriptional Reprogramming of B‐Cell Receptor Signaling and Antigen Presentation During Bovine Leukemia Virus–Driven Lymphomagenesis
Bovine leukemia virus (BLV), an oncogenic deltaretrovirus, establishes lifelong infection in cattle and induces enzootic bovine leukosis in a subset of animals following prolonged latency. Despite extensive evidence of immune dysregulation, stage‐specific transcriptional reprogramming of B cells, the primary viral reservoir remains incompletely understood. In this study, we performed a targeted RNA‐sequencing analysis to characterize B‐cell–associated transcriptional profiles across three clinical stages: uninfected controls (CT), asymptomatic BLV‐infected cattle (AC), and persistent lymphocytosis (PL). Differential gene expression analysis revealed a dynamic, stage‐dependent remodeling of B‐cell immune functions. Asymptomatic infection was characterized by significant upregulation of key B‐cell receptor (BCR) signaling components, including CD79B and SYK , alongside increased expression of major histocompatibility complex class II genes ( BoLA‐DRA, BoLA‐DRB3 ) and immunoglobulin assembly gene JCHAIN , indicating enhanced antigen responsiveness and partial activation of antibody‐related pathways. However, transcriptional regulators of terminal plasma cell differentiation ( PRDM1 and XBP1 ) remained unchanged, suggesting incomplete maturation. In contrast, progression to persistent lymphocytosis was associated with attenuation of canonical BCR signaling and reduced expression of antigen presentation and immunoglobulin assembly genes relative to the asymptomatic stage. Notably, germinal center–associated transcription factors ( BCL6, AICDA, RGS13, MEF2B ) remained largely unchanged across all comparisons, indicating that BLV‐driven lymphomagenesis does not resemble a classical germinal center–derived process. Collectively, these findings support a biphasic model of BLV‐induced B‐cell modulation, characterized by early immune activation followed by functional reprogramming and immune attenuation during disease progression. This stage‐dependent remodeling provides new mechanistic insights into BLV pathogenesis and B‐cell transformation.
- Open Access
- 3 March 2026
- Published by Springer Nature in Medical Oncology
- Vol. 43 (4)
Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis
Deltaretroviruses, including Human T-cell Leukemia Virus type 1 (HTLV-1) and Bovine Leukemia Virus (BLV), are oncogenic pathogens that exploit host transcriptional machinery to establish persistence and drive malignant transformation. Central to this process is the cAMP response element-binding protein (CREB), a transcription factor that regulates cell survival, proliferation, and differentiation. Viral proteins, such as Tax and HBZ, directly interact with CREB and its cofactors (CBP/p300, TORC2), enabling the robust activation of viral long terminal repeats (LTRs) and the dysregulation of host gene expression, including key regulators of apoptosis and the cell cycle. CREB phosphorylation and complex assembly with Tax and cofactors are critical steps in sustaining viral replication, anti-apoptotic signaling, and oncogenesis. Comparative studies highlight conserved roles of CREB in both HTLV-1 and BLV, where it not only mediates viral transcription but also contributes to immune evasion, genomic instability, and malignant progression. Epigenetic modulation and cellular factors, such as c-Maf and MEF-2, further refine CREB-dependent transcriptional outcomes, underscoring the intricate interplay between virus and host. Importantly, clinical data from patients with Adult T-cell Leukemia/Lymphoma (ATLL) show CREB overexpression and a correlation with viral gene expression, reinforcing its role in disease progression. Collectively, these findings establish CREB as a central hub in deltaretrovirus biology and pathogenesis. Targeting CREB signaling may therefore represent a promising therapeutic strategy for controlling both HTLV-1 and BLV-associated malignancies. This review integrates current knowledge of CREB's role in deltaretrovirus infection and highlights its potential as a therapeutic target for future antiviral and anticancer interventions.
- 3 March 2026
- Published by Springer Nature in Medical Oncology
- Vol. 43 (4)
Open AccessExploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis
Deltaretroviruses, including Human T-cell Leukemia Virus type 1 (HTLV-1) and Bovine Leukemia Virus (BLV), are oncogenic pathogens that exploit host transcriptional machinery to establish persistence and drive malignant transformation. Central to this process is the cAMP response element-binding protein (CREB), a transcription factor that regulates cell survival, proliferation, and differentiation. Viral proteins, such as Tax and HBZ, directly interact with CREB and its cofactors (CBP/p300, TORC2), enabling the robust activation of viral long terminal repeats (LTRs) and the dysregulation of host gene expression, including key regulators of apoptosis and the cell cycle. CREB phosphorylation and complex assembly with Tax and cofactors are critical steps in sustaining viral replication, anti-apoptotic signaling, and oncogenesis. Comparative studies highlight conserved roles of CREB in both HTLV-1 and BLV, where it not only mediates viral transcription but also contributes to immune evasion, genomic instability, and malignant progression. Epigenetic modulation and cellular factors, such as c-Maf and MEF-2, further refine CREB-dependent transcriptional outcomes, underscoring the intricate interplay between virus and host. Importantly, clinical data from patients with Adult T-cell Leukemia/Lymphoma (ATLL) show CREB overexpression and a correlation with viral gene expression, reinforcing its role in disease progression. Collectively, these findings establish CREB as a central hub in deltaretrovirus biology and pathogenesis. Targeting CREB signaling may therefore represent a promising therapeutic strategy for controlling both HTLV-1 and BLV-associated malignancies. This review integrates current knowledge of CREB's role in deltaretrovirus infection and highlights its potential as a therapeutic target for future antiviral and anticancer interventions.
- 31 December 2025
- Published by SAGE Publications in Viral Immunology
- Vol. 38 (9-10) , 303-316
COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.
- 31 December 2025
- Published by SAGE Publications in Viral Immunology
- Vol. 38 (9-10) , 303-316
COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.
- Open Access
Differential Gene Expression and Protein–Protein Interaction Networks in Bovine Leukemia Virus Infected Cattle: An RNA-Seq Study
Introduction: Bovine leukemia virus is a single-stranded RNA virus that targets B cell CD5+ lymphocytes in cattle. Only a tiny percentage of individuals develop malignant lymphoproliferative disorders, while most remain healthy carriers or experience persistent lymphocytosis. The exact mechanisms leading to lymphoma development are complex and not fully understood. RNA-seq analysis of cows’ peripheral blood leukocytes (PBLs) with and without Bovine leukemia virus (BLV) antibodies was conducted to gain a deeper understanding of molecular events beyond BLV infection. Method: Eighteen samples were selected, and their RNA was sequenced. For gene expression analysis and protein–protein network interactions, three groups were selected, including healthy negative samples (CT, n = 7), asymptomatic carriers (AC, n = 5), and persistent lymphocytosis (PL, n = 6), to provide the differentially expressed gene (DEG) and protein–protein interaction network (PPIN) outputs. Results: Our results demonstrated that in comparison to CT, ACs upregulated TLR7 and transcription activation factors. In the CT vs. PL group, MHC class II, transcription activation factors, and anti-inflammatory cytokines increased, while the acute-phase proteins, antiviral receptors, and inflammatory cytokines decreased. Additionally, antiviral receptors, acute-phase proteins, and inflammatory receptors were downregulated in the PL versus the AC groups. Moreover, PPINs analysis suggested that nuclear receptor corepressor 1 (NCOR1), serine/arginine repetitive matrix 2 (SRRM2), LUC7 like 3 pre-mRNA splicing factor (LUC7L3), TWIST neighbor (TWISTNB), U6 small nuclear RNA and mRNA degradation associated (LSM4), eukaryotic translation elongation factor 2 (EEF2), ubiquitin C (UBC), CD74, and heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNP A2B1) are possible hub gene candidates in the PL group. Conclusions: Our results suggest that innate and cellular immune responses are more loose in severe BLV infectious conditions, while the PPINs revealed that new protein interactions are necessary for oncogenesis.
Open AccessDifferential Gene Expression and Protein–Protein Interaction Networks in Bovine Leukemia Virus Infected Cattle: An RNA-Seq Study
Introduction: Bovine leukemia virus is a single-stranded RNA virus that targets B cell CD5+ lymphocytes in cattle. Only a tiny percentage of individuals develop malignant lymphoproliferative disorders, while most remain healthy carriers or experience persistent lymphocytosis. The exact mechanisms leading to lymphoma development are complex and not fully understood. RNA-seq analysis of cows’ peripheral blood leukocytes (PBLs) with and without Bovine leukemia virus (BLV) antibodies was conducted to gain a deeper understanding of molecular events beyond BLV infection. Method: Eighteen samples were selected, and their RNA was sequenced. For gene expression analysis and protein–protein network interactions, three groups were selected, including healthy negative samples (CT, n = 7), asymptomatic carriers (AC, n = 5), and persistent lymphocytosis (PL, n = 6), to provide the differentially expressed gene (DEG) and protein–protein interaction network (PPIN) outputs. Results: Our results demonstrated that in comparison to CT, ACs upregulated TLR7 and transcription activation factors. In the CT vs. PL group, MHC class II, transcription activation factors, and anti-inflammatory cytokines increased, while the acute-phase proteins, antiviral receptors, and inflammatory cytokines decreased. Additionally, antiviral receptors, acute-phase proteins, and inflammatory receptors were downregulated in the PL versus the AC groups. Moreover, PPINs analysis suggested that nuclear receptor corepressor 1 (NCOR1), serine/arginine repetitive matrix 2 (SRRM2), LUC7 like 3 pre-mRNA splicing factor (LUC7L3), TWIST neighbor (TWISTNB), U6 small nuclear RNA and mRNA degradation associated (LSM4), eukaryotic translation elongation factor 2 (EEF2), ubiquitin C (UBC), CD74, and heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNP A2B1) are possible hub gene candidates in the PL group. Conclusions: Our results suggest that innate and cellular immune responses are more loose in severe BLV infectious conditions, while the PPINs revealed that new protein interactions are necessary for oncogenesis.
- Open Access
- 6 August 2025
- Published by Wiley in Analytical Science Advances
- Vol. 6 (2) , e70026
Spectrometry and Its Application for the Detection of RNA‐Binding Proteins: Advancements, Techniques and Challenges
Spectrometry is a fascinating field of analytical science that encompasses a range of techniques used to study the interaction between electromagnetic radiation and matter. Through the measurement and analysis of various radiations, spectrometry provides valuable insights into the composition, structure and properties of different substances. Spectrometry allows for the identification and quantification of proteins based on their characteristics and abundance. By comparing the mass spectrometry data obtained from the pulldown assay with databases of known proteins, it is possible to identify the interacting proteins with high confidence. Long non‐coding RNAs (lncRNAs), as one of the most important RNA‐binding proteins, have emerged as key players in gene regulation, with nearly 80% of transcripts in human cells being lncRNA species. These nonprotein‐coding transcripts, longer than 200 nucleotides, have shown great potential in various biological processes and diseases. However, their functional characterization remains a challenge due to their lower expression levels and the limitations of current techniques. Therefore, in this study, we aim to review spectrometry and its diverse types for application in the determination of general properties of RNA‐binding proteins.
- 6 August 2025
- Published by Wiley in Analytical Science Advances
- Vol. 6 (2) , e70026
Open AccessSpectrometry and Its Application for the Detection of RNA‐Binding Proteins: Advancements, Techniques and Challenges
Spectrometry is a fascinating field of analytical science that encompasses a range of techniques used to study the interaction between electromagnetic radiation and matter. Through the measurement and analysis of various radiations, spectrometry provides valuable insights into the composition, structure and properties of different substances. Spectrometry allows for the identification and quantification of proteins based on their characteristics and abundance. By comparing the mass spectrometry data obtained from the pulldown assay with databases of known proteins, it is possible to identify the interacting proteins with high confidence. Long non‐coding RNAs (lncRNAs), as one of the most important RNA‐binding proteins, have emerged as key players in gene regulation, with nearly 80% of transcripts in human cells being lncRNA species. These nonprotein‐coding transcripts, longer than 200 nucleotides, have shown great potential in various biological processes and diseases. However, their functional characterization remains a challenge due to their lower expression levels and the limitations of current techniques. Therefore, in this study, we aim to review spectrometry and its diverse types for application in the determination of general properties of RNA‐binding proteins.
- 1 March 2024
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 40 (3) , 141-147
Assessment of Bcl-xL , TAX , and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients
Introduction: Adult T-cell leukemia/lymphoma is a malignancy with a poor prognosis caused by HTLV-1 infection. TAX and HBZ are two major viral proteins that may be involved in oncogenesis by disrupting apoptosis. Because Bcl-xL plays an integral role in the anti-apoptotic pathway, this study examines the interaction between host apoptosis and oncoproteins. Method and Material: We investigated 37 HTLV-1-infected individuals, including 18 asymptomatic and 19 ATLL subjects. mRNA was extracted and converted to cDNA from peripheral blood mononuclear cells (PBMCs), and then gene expression was determined using TaqMan qPCR. Moreover, the HTLV-I proviral load was also measured using a commercial absolute quantification kit (Novin Gene, Iran). Results: Data analysis revealed that the mean of TAX, HBZ, and PVL was significantly higher among the study groups (ATLL and carriers groups P= (0.003), P= (0.000), and P= (0.002) respectively). There was no statistical difference in Bcl-xL gene expression between studies groups (P=0.323). Conclusion: It is proposed that this anti-apoptotic pathway may not be directly involved in the development of ATLL lymphoma. TAX, HBZ gene expression, and PVL can be utilized as prognostic markers. Keywords: HTLV-1, ATLL, HBZ, TAX, Bcl-xL, Apoptosis
- 1 March 2024
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 40 (3) , 141-147
Assessment of Bcl-xL , TAX , and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients
Introduction: Adult T-cell leukemia/lymphoma is a malignancy with a poor prognosis caused by HTLV-1 infection. TAX and HBZ are two major viral proteins that may be involved in oncogenesis by disrupting apoptosis. Because Bcl-xL plays an integral role in the anti-apoptotic pathway, this study examines the interaction between host apoptosis and oncoproteins. Method and Material: We investigated 37 HTLV-1-infected individuals, including 18 asymptomatic and 19 ATLL subjects. mRNA was extracted and converted to cDNA from peripheral blood mononuclear cells (PBMCs), and then gene expression was determined using TaqMan qPCR. Moreover, the HTLV-I proviral load was also measured using a commercial absolute quantification kit (Novin Gene, Iran). Results: Data analysis revealed that the mean of TAX, HBZ, and PVL was significantly higher among the study groups (ATLL and carriers groups P= (0.003), P= (0.000), and P= (0.002) respectively). There was no statistical difference in Bcl-xL gene expression between studies groups (P=0.323). Conclusion: It is proposed that this anti-apoptotic pathway may not be directly involved in the development of ATLL lymphoma. TAX, HBZ gene expression, and PVL can be utilized as prognostic markers. Keywords: HTLV-1, ATLL, HBZ, TAX, Bcl-xL, Apoptosis
- 7 June 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 169, 105622
HTLV, a multi organ oncovirus
- 7 June 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 169, 105622
HTLV, a multi organ oncovirus
- Open Access
- 19 July 2021
- Published by Springer Nature in Research Square
Pimpinella Anisum Extracts, Safe Anti-Bacterial Treatment
Introduction: Now a day, antibiotic-resistant bacteria are increasing and became a medical worldwide problem, therefore the achievement of a new safe disinfectant is deemed necessary. Pimpinella anisum (Pa) is an aromatic plant, belonging to the Umbelliferae family. It is a well-known traditional medicinal herb that has been used in old medicine as an antibacterial, anticancer, antiulcer, therefore, the aim of this study is evaluation of the anti-bacterial effect of PA extracts against Probiotics and pathogens bacteria. Method: 96-well microplates MICs were determined by the broth microdilution method. Five Serial dilutions from 50 to 1 μg/mL concentrations were admitted for all bacteria which include: Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 25923, and Probiotics complex. Results: PA watery extract demonstrates a statically inhibitory effect in just 50 g/L concentration against E.Coli, E. Faecalis, and Probiotic p= 0.000 for all, whereas this concentration was 25 g/L for Staph. Aureus and Pu p=0.000 and p= 0.007 respectively. PA alcohol extract displays the same effect in 1g/L for all bacteria p= 0.000 for all bacteria. Conclusion: Our results showed that PA in both watery and Alcohol extractions can inhibit both pathogenic and non-pathogen bacteria whereas active compounds are alcohol soluble. Long-time consumption of PA in an herbal product could disrupt normal bacteria of the gastrointestinal system while PA watery extract can promote Probiotics.
- 19 July 2021
- Published by Springer Nature in Research Square
Open AccessPimpinella Anisum Extracts, Safe Anti-Bacterial Treatment
Introduction: Now a day, antibiotic-resistant bacteria are increasing and became a medical worldwide problem, therefore the achievement of a new safe disinfectant is deemed necessary. Pimpinella anisum (Pa) is an aromatic plant, belonging to the Umbelliferae family. It is a well-known traditional medicinal herb that has been used in old medicine as an antibacterial, anticancer, antiulcer, therefore, the aim of this study is evaluation of the anti-bacterial effect of PA extracts against Probiotics and pathogens bacteria. Method: 96-well microplates MICs were determined by the broth microdilution method. Five Serial dilutions from 50 to 1 μg/mL concentrations were admitted for all bacteria which include: Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 25923, and Probiotics complex. Results: PA watery extract demonstrates a statically inhibitory effect in just 50 g/L concentration against E.Coli, E. Faecalis, and Probiotic p= 0.000 for all, whereas this concentration was 25 g/L for Staph. Aureus and Pu p=0.000 and p= 0.007 respectively. PA alcohol extract displays the same effect in 1g/L for all bacteria p= 0.000 for all bacteria. Conclusion: Our results showed that PA in both watery and Alcohol extractions can inhibit both pathogenic and non-pathogen bacteria whereas active compounds are alcohol soluble. Long-time consumption of PA in an herbal product could disrupt normal bacteria of the gastrointestinal system while PA watery extract can promote Probiotics.
- Open Access
- 3 August 2019
- Published by Brieflands in Modern Care Journal
- Vol. 16 (3)
Sero-Prevalence of Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Positive Patients in Mashhad, Northeastern Iran
- 3 August 2019
- Published by Brieflands in Modern Care Journal
- Vol. 16 (3)
Open AccessSero-Prevalence of Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Positive Patients in Mashhad, Northeastern Iran